Annual workforce figures released today by the RCR reveal the continuing struggle to staff cancer centres. Clinical oncology leaders have questioned how the NHS will be able to rollout cutting-edge life-saving innovations – such as immunotherapy drugs and high energy proton beam radiotherapy – without more investment.
Home page 1
- Clinical oncology UK workforce census 2018 report There has been a 2x increase in the number of vacant clinical oncologist roles over the last five years
- Clinical oncology UK workforce census 2018 report The current 18% shortfall in consultant clinical oncologists is forecast to increase to 22% by 2023
- Clinical oncology UK workforce census 2018 report 1 in 6 UK cancer centres now have fewer consultants working for them than five years ago
- Clinical oncology UK workforce census 2018 report The number of consultants leaving the profession each year is forecast to increase from 3.6% to 4.6% by 2023
- Clinical oncology UK workforce census 2018 report Incentivising those planning to retire to leave at age 65 – instead of 60 – would retain nearly 100 consultants over the next five years
- Clinical oncology UK workforce census 2018 report The UK needs 2x the current number of trainees to meet the minimum number of clinical oncologists needed for 2023
- Clinical oncology UK workforce census 2018 report Almost 1 in 4 full-time consultants are contracted to work over 48 hours per week, with many doing additional unpaid overtime
RCR workforce report highlights continuing struggle to staff UK cancer centres
The Royal College of Radiologists (RCR) leads, educates and supports doctors who are training and working in the specialties of clinical oncology and clinical radiology
No-deal Brexit guidance for nuclear medicine teams
Tuesday 5 March 2019
Results of the College and Faculty Elections 2019
Tuesday 12 March 2019
Working in the UK
Four consultant radiologists trained abroad but now working in the UK, talk about their move to the UK and what it’s like to live and work here.
Oncology journalsClinical Oncology brings you a combination of high-quality original research, editorials and state-of-the-art reviews on all aspects of the clinical management of cancer patients and also key pre-clinical and translational oncology research.